N4 Pharma Statistics

Total Valuation

N4 Pharma has a market cap or net worth of GBP 3.95 million. The enterprise value is 2.23 million.

Market Cap	3.95M
Enterprise Value	2.23M

Important Dates

The next estimated earnings date is Monday, March 9, 2026.

Earnings Date	Mar 9, 2026
Ex-Dividend Date	n/a

Share Statistics

N4 Pharma has 832.28 million shares outstanding. The number of shares has increased by 80.86% in one year.

Current Share Class	832.28M
Shares Outstanding	832.28M
Shares Change (YoY)	+80.86%
Shares Change (QoQ)	+45.46%
Owned by Insiders (%)	19.50%
Owned by Institutions (%)	56.32%
Float	517.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	559.49
PB Ratio	2.24
P/TBV Ratio	2.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.02
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.55

Current Ratio	23.55
Quick Ratio	23.55
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -74.18% and return on invested capital (ROIC) is -49.29%.

Return on Equity (ROE)	-74.18%
Return on Assets (ROA)	-47.21%
Return on Invested Capital (ROIC)	-49.29%
Return on Capital Employed (ROCE)	-67.97%
Weighted Average Cost of Capital (WACC)	5.20%
Revenue Per Employee	1,767
Profits Per Employee	-275,576
Employee Count	4
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-69,733
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.39% in the last 52 weeks. The beta is 0.17, so N4 Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	-17.39%
50-Day Moving Average	0.50
200-Day Moving Average	0.51
Relative Strength Index (RSI)	5.41
Average Volume (20 Days)	299,158

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, N4 Pharma had revenue of GBP 7,066 and -1.10 million in losses. Loss per share was -0.00.

Revenue	7,066
Gross Profit	7,066
Operating Income	-1.20M
Pretax Income	-1.20M
Net Income	-1.10M
EBITDA	n/a
EBIT	-1.20M
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 1.73 million in cash and n/a in debt, with a net cash position of 1.73 million or 0.00 per share.

Cash & Cash Equivalents	1.73M
Total Debt	n/a
Net Cash	1.73M
Net Cash Per Share	0.00
Equity (Book Value)	1.77M
Book Value Per Share	0.00
Working Capital	1.77M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.02M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-17,000.69%
Pretax Margin	-16,977.24%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

N4 Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-80.86%
Shareholder Yield	-80.86%
Earnings Yield	-27.88%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

N4 Pharma has an Altman Z-Score of 9.87 and a Piotroski F-Score of 2.

Altman Z-Score	9.87
Piotroski F-Score	2